Biological evaluation of a series of 2-acetamido-2-deoxy-D-glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro

Glycoconjugate Journal

Volumn 22, Issue 7-9, 2005, Pages 443-451

  Berkin, Ali ^a   Szarek, Walter A ^a   Kisilevsky, Robert ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

2 acetamido 2 deoxy D glucose; Glycosaminoglycan; Heparan sulfate; Protein synthesis; Proteoglycans

Indexed keywords

2 ACETAMIDO 1,3,4,6 TETRA 2 ACETYL 2 DEOXY DEXTRO GLUCOPYRANOSE; 2 ACETAMIDO 1,3,6 TRI 2 ACETYL 2,4 DIDEOXY DEXTRO XYLO HEXOPYRANOSE; 2 ACETAMIDO 3,4,6 TRI 2 ACETYL 1,5 ANHYDRO 2 DEOXY DEXTRO GLUCITOL; AMINOGLYCOSIDE DERIVATIVE; BETA DEXTRO XYLO HEXOPYRANOSIDE; CARBON 14; ENZYME INHIBITOR; GLUCOPYRANOSIDE; GLUCOSAMINE; GLYCOSAMINOGLYCAN; LEUCINE; METHYL 2 ACETAMIDO 3,4,6 TRI 2 ACETYL 2 DEOXY ALPHA; METHYL 2 ACETAMIDO 3,6 DI 2 ACETYL 2,4 DIDEOXY ALPHA; PROTEIN; SULFATE; SULFUR 35; TRITIUM; UNCLASSIFIED DRUG; URIDINE; URIDINE DIPHOSPHATE SUGAR; URIDINE TRIPHOSPHATE;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CARBOHYDRATE METABOLISM; CELL CULTURE; CELL METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPLETION; DILUTION; FEMALE; GLYCOSAMINOGLYCAN METABOLISM; IN VITRO STUDY; ISOLATION PROCEDURE; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REDUCTION;

ACETYLGLUCOSAMINE; ANIMALS; CELLS, CULTURED; FEMALE; GLUCOSAMINE; GLYCOSAMINOGLYCANS; HEPATOCYTES; LEUCINE; MICE; PROTEIN BIOSYNTHESIS; SULFATES;

ANIMALIA;

EID: 28344452124     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-005-5060-1     Document Type: Article

References (48)

1. Poole AR, Biochem J 236, 1-14 (1986).
2. Hook M, Annu Rev Biochem 53, 847-69 (1984).
3. LeBaron RG, Hook A, Esko JD, Gay S, Hook M, J Biol Chem 264, 7950-6 (1989).
4. Gallagher JT, Lyon M, Steward WP, Biochem J 236, 313-25 (1986).
5. Ruoslahti E, Annu Rev Cell Biol 4, 229-55 (1988).
6. Keller KL, Keller JM, May JN, Biochemistry 19, 2529-36 (1980).
7. Esko JD, Rostand S, Weinke JL, Science 241, 1092-6 (1988).
8. Johnson KH, O'Brien TD, Betsholtz C, Westermark P, Lab Invest 66, 522-35 (1992).
9. Kjellen L, Bielefeld D, Höök M, Diabetes 32, 337-42 (1983).
10. WuDunn D, Spear PG, J Virol 63, 52-8 (1989).
11. Shieh M-T, WuDunn D, Montgomery RI, Esko JD, Spear PG, J Cell Biol 116, 1273-81 (1992).
12. Leong JM, Robbins D, Rosenfeld L, Lahiri B, Parveen N, Infec Immun 66, 6045-8 (1998).
13. Chen JCR, Stephens RS, Microb Pathog 22, 23-30 (1997).
14. Chen Q, Barragan A, Fernandez V, Sundström A, Schlichtherle M, Sahlén A, Carlson J, Datta S, Wahlgren M, J Exp Med 187, 15-23 (1998).
15. Coppel RL, Brown GV, Nussenzweig V, Curr Opin Microbiol 1, 472-81 (1998).
16. Sinnis P, Sim BKL, Trends Microbiol 5, 52-8 (1997).
17. Snow AD, Sekiguchi RT, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG, Neuron 12, 219-34 (1994).
18. Snow AD, Sekiguchi RT, Nochlin D, Kalaria D, Kimata K, Am J Pathol 144, 337-47 (1994).
19. Lindahl B, Eriksson L, Lindahl U, Biochem J 306, 177-84 (1995).
20. Thomas SS, Plenkiewicz J, Ison ER, Bols M, Zou W, Szarek WA, Kisilevsky R, Biochim Biophys Acta 1272, 37-48 (1995).
21. Dow KE, Riopelle RJ, Szarek WA, Bols M, Ison ER, Plenkiewicz J, Lyon A, Kisilevsky R, Biochim Biophys Acta 1156, 7-14 (1992).
22. Berkin A, Szarek WA, Kisilevsky R, Carbohydr Res 326, 250-63 (2000).
23. Ledbetter SR, Hassell JR, Arch Biochem Biophys 246, 403-10 (1986).
24. Fritz TA, Lugemwa FN, Sarkar AK, Esko JD, J Biol Chem 269, 300-7 (1994).
25. Lugemwa FN, Esko JD, J Biol Chem 266, 6674-7 (1991).
26. Lugemwa FN, Esko JD, Carbohydr Res 239, 285-90 (1993).
27. Miao HQ, Fritz TA, Esko JD, Zimmermann J, Yayon A, Vlodavsky I, J Cell Biochem 57, 173-84 (1995).
28. Parry G, Farson D, Cullen B, Bissell MJ, In Vitro 24, 1217-22 (1988).
29. Sudhakaran R, Sinn W, von Figura K, Hoppe-Seyler's Z Physiol Chem 362, 39-46 (1981).
30. Margolis RK, Goossen B, Tekotte H, Hilgenberg L, Margolis RU, J Cell Sci 99, 237-46 (1991).
31. van Kuppevelt THSM, Van de Lest CHA, Versteeg EMM, Dekhuijzen PNR, Veerkamp JH, Amer J Respir Cell Mol Biol 16, 75-84 (1997).
32. Bernacki RJ, Korytnyk W, Development of membrane sugar and nucleotide sugar analogs as potential inhibitors or modifiers of cellular glycoconjugates. In The glycoconjugates, Vol. 4, Part B, edited by Horowitz MI (Academic Press, New York, 1982), pp. 245-63.
33. Sharma M, Bernacki RJ, Paul B, Korytnyk W, Carbohydr Res 198, 205-21 (1990).
34. Paul B, Bernacki RJ, Korytnyk W, Carbohydr Res 80, 99-115 (1980).
35. Subrahmanyan L, Kisilevsky R, Scand J Immunol 27, 251-60 (1988).
36. Kisilevsky R, Subrahmanyan L, Lab Invest 66, 778-85 (1992).
37. Hronowski L, Anastassiades TP, J Biol Chem 255, 9210-17 (1980).
38. Inouye Y, Onodera K, Kitaoka S, Ochiai H, J Am Chem Soc 79, 4218-22 (1957).
39. Hudson CS, Dale JK, J Am Chem Soc 38, 1431-36 (1916).
40. Berkin A, Szarek MA, Plenkiewicz J, Szarek WA, Kisilevsky R, Carbohydr Res 325, 30-45 (2000).
41. Horton D, Wolfrom ML, J Org Chem 27, 1794-1800 (1962).
42. Thomas SS, M.Sc. Thesis, Queen's University, Kingston, Ontario (1991).
43. Bernacki RJ, Sharma M, Porter NK, Rustum Y, Paul B, Korytnyk W, Supramol Struct 7, 235-50 (1977).
44. Decker K, Keppler D, In Progress in liver disease, Vol. 4, edited by Popper H, Schaffner F (Grune & Stratton, New York, 1972), pp. 183-99.
45. Decker K, Keppler D, Rev Physiol Biochem Pharmacol 71, 77-106 (1974).
46. Roeser KR, Legler G, Biochim Biophys Acta 657, 321-33 (1981).
47. McCarter JD, Adam MJ, Withers SG, Biochem J 286, 721-7 (1992).
48. Berkin A, Szarek WA, Kisilevsky R, Carbohydr Res 337, 37-44 (2002).